BOSTON, Jan. 9, 2015 /PRNewswire/ -- Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its recapitalization and equity investment by Ampersand Capital Partners. Founded in 1998, CutisPharma develops and commercializes FIRST® unit-of-use prescription compounding kits to aid pharmacists in the preparation of compounded prescriptions. CutisPharma’s rapidly expanding portfolio of kits is utilized in retail and hospital pharmacies across the United States. Johnston Blakely initiated the transaction with Ampersand and acted as financial advisor to CutisPharma.
“The Johnston Blakely team did a terrific job assisting us execute this partnership with Ampersand,” commented Indu Muni, Ph.D., founder, Chairman and CEO of CutisPharma. “They helped us articulate our business in a clear, concise manner and skillfully advised on driving the transaction to a successful and desired outcome.”
“We believe Ampersand and CutisPharma are a great fit and were delighted to help facilitate this transaction,” stated Benjamin Conway, managing director of Johnston Blakely. “Ampersand offers CutisPharma a wealth of industry-specific knowledge and has particular experience in the compounding pharmacy sector that will prove invaluable to CutisPharma as it aggressively pursues its longer-term strategic objectives.”
About Johnston Blakely & Company
Johnston Blakely & Company, LLC, a CMC Group subsidiary, is a US broker-dealer focused on the life science sectors. Johnston Blakely provides private equity capital brokerage and M&A advisory services to companies in the biotechnology, specialty pharmaceutical, medical device and diagnostic sectors and the ancillary services sectors.
About the CMC Group
The CMC Group is an international advisory firm providing integrated transaction services, management and medical affairs consulting to companies in the life science industries. This integration provides clients a seamless interface between strategy and implementation and incorporates a range of perspectives designed to optimize engagement outcomes. With offices in the United States, Asia and throughout the EU, the firm complements global industry knowledge with rich local market insight.
Johnston Blakely & Company, LLC is registered broker/dealer. Member FINRA/SIPC.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnston-blakely--company-advises-cutispharma-on-equity-financing-300018026.html
SOURCE CMC Group
Help employers find you! Check out all the jobs and post your resume.
